Evidence map›Paper›PMID 27139523›Full record

Trial reportJournal of palliative medicine2016

More with Less: A Trial of Reduced-Intensity Treatment in Transplant-Ineligible Hemodialysis Patients.

Nathaniel Berman, M Carrington Reid, Jeanne Teresi, Joseph P Eimicke, Ronald Adelman

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of palliative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01775800 (Treatment Modification and Symptom Burden in High-Risk Dialysis Patients), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01775800 nacompletednot on this map

Treatment Modification and Symptom Burden in High-Risk Dialysis Patients

TypeinterventionalSponsorThe Rogosin InstituteRan2013 to 2014Enrolled16ConditionsEnd Stage Renal DiseaseArmsTreatment modification
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathaniel Berman1 Division of Nephrology and Hypertension, Weill Cornell Medical College , New York, New York.
M Carrington Reid3 Division of Geriatrics and Palliative Care, Weill Cornell Medical College , New York, New York.
Jeanne Teresi4 Research Division, Hebrew Home at Riverdale, RiverSpring Health , Bronx, New York.
Joseph P Eimicke3 Division of Geriatrics and Palliative Care, Weill Cornell Medical College , New York, New York.
Ronald Adelman3 Division of Geriatrics and Palliative Care, Weill Cornell Medical College , New York, New York.

Funding

Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Pilot CoreP30AG022845 · NIA · WEILL MEDICAL COLL OF CORNELL UNIV · PI Manney Carrington Reid, ELAINE WETHINGTON · 2003 to 2026
$15.2M
NCATS NIH HHS UL1 TR002384NIA NIH HHS P30 AG022845
6 · The paper itself

Abstract

backgroundAn increasing proportion of hemodialysis patients are ineligible for transplant. Often these patients are elderly, with multiple comorbidities and decreased functional status. Such patients may benefit from modified treatment goals to reduce symptom burden.

objectiveTo demonstrate the feasibility of a trial of reduced-intensity treatment in nontransplantable patients with end-stage renal disease (ESRD). STUDY

designA 6-week study randomized patients to a reduced-intensity intervention versus usual care. Intervention subjects were treated with liberalized goals for serum phosphorus and parathyroid hormone (PTH) as well as predialysis blood pressure in comparison with usual care subjects. Outcomes included assessed feasibility of recruitment, randomization, and data collection. SETTING AND POPULATION: Sixteen transplant-ineligible hemodialysis patients were recruited from two urban units. MEASUREMENTS: Blood pressure was recorded weekly, while serum PTH and phosphorus were assessed every 10 days. A quality-of-life measure was administered before and after the trial.

resultsOf 300 patients, 51 were eligible and 16 consented. All were randomized and completed the trial. Patients in the intervention group received significantly lower doses of phosphorus binders and vitamin D analogues, and were less likely to have their dry weight reduced. All patient surveys were completed.

conclusionsHigh-risk hemodialysis patients may benefit from liberalized treatment guidelines but larger studies are necessary.

Indexed as

Renal DialysisComorbidityHumansKidney Failure, ChronicParathyroid HormonePhosphorusParathyroid HormonePhosphorus

Identifiers

PMID27139523
PMCPMC4860662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.